Green Cross Holdings banner

Green Cross Holdings
KRX:005250

Watchlist Manager
Green Cross Holdings Logo
Green Cross Holdings
KRX:005250
Watchlist
Price: 13 290 KRW -5.41% Market Closed
Market Cap: ₩636.2B

Gross Margin

27.5%
Current
Declining
by 1.7%
vs 3-y average of 29.2%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
27.5%
=
Gross Profit
₩660B
/
Revenue
₩2.4T

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
27.5%
=
Gross Profit
₩660B
/
Revenue
₩2.4T

Peer Comparison

Country Company Market Cap Gross
Margin
KR
Green Cross Holdings
KRX:005250
603.4B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
407.9B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
197.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
178.6B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.4B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.4B USD
Loading...
AU
CSL Ltd
ASX:CSL
68.5B AUD
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
NL
argenx SE
XBRU:ARGX
38.1B EUR
Loading...

Market Distribution

In line with most companies in Korea
Percentile
64th
Based on 2 511 companies
64th percentile
27.5%
Low
-646.5% — 12.8%
Typical Range
12.8% — 32.2%
High
32.2% — 54 001.3%
Distribution Statistics
Korea
Min -646.5%
30th Percentile 12.8%
Median 19.7%
70th Percentile 32.2%
Max 54 001.3%

Green Cross Holdings
Glance View

Market Cap
636.2B KRW
Industry
Biotechnology

Green Cross Holdings Corp. is a holding company of Green Cross Corp. that engages in the manufacture of pharmaceutical products. The company is headquartered in Yongin, Gyeonggi-Do. The Company’s products portfolio consists of prescription drugs, blood derivatives, vaccines, cerebrovascular disease treatment, hunter syndrome drugs, as well as over the counter (OTC) drugs, such as skin disease treatment drugs, allergic cream and others. Its products are used for analgesic, treatment of cerebral thrombosis, hypoalbuminemia, genodermatosis and others, as well as prevention of influenza, prophylaxis of varicella, among others. The firm is also involved in the real estate sales and leasing, as well as construction business.

Intrinsic Value
83 206.38 KRW
Undervaluation 84%
Intrinsic Value
Price
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
27.5%
=
Gross Profit
₩660B
/
Revenue
₩2.4T
What is Green Cross Holdings's current Gross Margin?

The current Gross Margin for Green Cross Holdings is 27.5%, which is below its 3-year median of 29.2%.

How has Gross Margin changed over time?

Over the last 3 years, Green Cross Holdings’s Gross Margin has decreased from 33.5% to 27.5%. During this period, it reached a low of 27.5% on Sep 30, 2025 and a high of 33.6% on Dec 31, 2022.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett